Products
Online Inquiry
Golvatinib (E7050)
Cat. No.:
OB0225WX-2526
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Golvatinib (E7050) is a dual-target kinase inhibitor that suppresses both c-Met and VEGFR-2 with potent IC50 values of 14 nM and 16 nM, respectively.
Synonym:
Golvatinib; 928037-13-2; Golvatinib (E7050); E-7050; E7050; 1-N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-[2-Fluoro-4-[[2-[[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl]amino]pyridin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-(2-Fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; golvatinibum; N'-(2-fluoro-4-(2-((4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)amino)pyridin-4-yl)oxyphenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N'1-(2-fluoro-4-((2-((4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)amino)pyridin-4-yl)oxy)phenyl)-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N'1-{2-fluoro-4-[(2-{[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino}pyridin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-(2-Fluoro-4-{[2-({[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl}amino)pyridin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-[2-Fluoro-4-[[2-[[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]amino]-4-pyridinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; N-[2-Fluoro-4-[[2-[[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl]amino]pyridin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; E-7050; E7050; MFCD22124462; 1,1-Cyclopropanedicarboxamide, N-(2-fluoro-4-((2-(((4-(4-methyl-1-piperazinyl)-1- piperidinyl)carbonyl)amino)-4-pyridinyl)oxy)phenyl)-N'-(4-fluorophenyl)-
CAS No.:
928037-13-2
Compound CID:
16118392
Formula:
C33H37F2N7O4
Formula Weight:
633.69
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Golvatinib (E7050) is applied in cancer research as a dual c-Met and VEGFR2 inhibitor to investigate the simultaneous suppression of tumor growth factor signaling and angiogenesis.
Library Information
Target:
c-Met; VEGFR
Receptor:
c-Met; VEGFR
Pathways:
Protein tyrosine kinase
Plate Number:
L6700-04
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
20 mg/mL; 31.56 mM
ALogP:
3.173
HBA_Count:
5
HBD_Count:
3
Rotatable Bond:
8





